Juliane Zielonka
Born in Bielefeld, she studied German, English and psychology. The emergence of the Internet in the early '90s led her from university to training in graphic design and marketing communications. After years of agency work in corporate branding, she switched to publishing and learned her editorial craft at Hubert Burda Media.
She discovered the world of the stock market in 1998. With her passion for innovation and digitalization, she focused on companies from the technology and healthcare sectors early on.
Analyzing fundamentals, business models and their scalability is as much her passion as thinking into complex future scenarios. Since 2019, she has regularly organized stock exchange roundtables and attended international investment events to deepen and pass on her knowledge.
Commented by Juliane Zielonka
Commented by Juliane Zielonka on August 30th, 2024 | 06:30 CEST
VCI Global, Intel, and Amazon: Paving the way for innovation and growth in the digital era
While established technology giants are looking for new ways to stay relevant, emerging companies and industry leaders are seizing the opportunities of the digital age. VCI Global demonstrates impressive growth in promising areas. Intel and IBM forge a promising alliance in the AI sector to regain lost ground. Amazon's AWS is driving scientific breakthroughs with its Parallel Computing Service that could potentially revolutionize the energy supply of the future. These three companies show how innovation, strategic partnerships, and bold visions are shaping the economic landscape of tomorrow - and offer investors fascinating insights into potential growth opportunities.
Read
Commented by Juliane Zielonka on August 23rd, 2024 | 07:15 CEST
Vidac Pharma, Bavarian Nordic, Palantir - Dream team in travel health and AI: 3 companies in focus
According to Marketresearch.biz, the travel health market is experiencing considerable growth. It is expected to grow from USD 78.5 billion in 2022 to USD 475.8 billion by 2032. This corresponds to an impressive annual growth rate of 20.3% between 2023 and 2032. Travel health can mean avoiding skin cancer while on vacation, but if it does occur, Vidac Pharma is at the forefront with a personalized medicine approach that excites investors. Listening to the WHO, it is clear that monkeypox is once again spreading and posing health risks. As a German-Danish biotech company, Bavarian Nordic has the vaccine answer and is revising its forecasts upwards thanks to strong market demand. Anyone travelling should also keep an eye on geopolitical tensions. Palantir has recently made a name for itself by supporting governments with AI products. Now, Palantir is bringing on board a man with an immense track record in US politics. Today, we focus on three promising investment opportunities.
Read
Commented by Juliane Zielonka on August 22nd, 2024 | 07:00 CEST
RWE, dynaCERT, Mercedes-Benz: Energy of the future - Hydrogen vs Electric
The energy transition is at the center of the strategies of RWE, dynaCERT, and Mercedes-Benz, each with different emphases. The energy company RWE is driving forward its hydrogen strategy with billions in investment and state subsidies. The Company plans to build electrolysers and hydrogen storage facilities, which, according to its IR Factbook, are the most promising components of its energy mix in the future. dynaCERT and its portfolio company Cipher Neutron are also focusing on innovative hydrogen solutions. Its AEM electrolysis technology, which is being researched in collaboration with Simon Fraser University, promises more efficient and cost-effective methods of hydrogen production. Mercedes-Benz, on the other hand, is struggling with the weaknesses of electric batteries. A severe fire involving an EV-Mercedes in an underground garage required over 8 hours of firefighting efforts, damaging 108 other vehicles and significantly damaging its reputation in one of its key markets...
Read
Commented by Juliane Zielonka on August 16th, 2024 | 06:30 CEST
Bavarian Nordic, Saturn Oil + Gas, Palantir - Monkeypox vaccine, energy, and defense in focus
A new global virus threat is waiting in the wings. Bavarian Nordic, a German-Danish biotech company for vaccines, is moving into the spotlight given the WHO's renewed monkeypox warning. Ten million vaccine doses are to be delivered to Africa by 2025. In the energy sector, the latest quarterly results from Saturn Oil & Gas are attracting the attention of investors and analysts. The Canadian company recorded growth of a whopping 50%. Palantir Technologies announced a partnership with Microsoft to provide cloud, AI, and analytics solutions for the US defense and intelligence community. Today, we focus on three industries with growth opportunities.
Read
Commented by Juliane Zielonka on August 15th, 2024 | 07:45 CEST
Starbucks, First Hydrogen, Amazon - Which industry has the greatest growth potential?
The markets are on the move. Large companies such as Starbucks are facing new challenges as the system catering business stagnates. A rigorous CEO replacement is now intended to bring both the team and shareholders back to the core of the coffee roasting company: Entrepreneurial spirit, customer friendliness, and innovation. Brian Niccol, who has already set other system catering businesses on the road to success, has been appointed to the helm with these key words. All hopes are now pinned on him. In the booming hydrogen market, the Canadian company First Hydrogen has an entirely different set of challenges. With a focus on the logistics sector, the team is concentrating on developing a delivery van that companies like Amazon & Co can use. Initial tests under real-life conditions bode well: the First Hydrogen vehicle can cover a whopping 630 km on a single tank of hydrogen. Like Starbucks, Amazon is experiencing a slowdown in growth. New competitors, particularly from China, are appearing on the e-commerce scene. However, the Seattle-based company has a growth strategy that uses AI. Where is the greatest growth potential for investors?
Read
Commented by Juliane Zielonka on August 9th, 2024 | 06:30 CEST
Cardiol Therapeutics, Novo Nordisk, Bayer - Pharma stocks in focus
The healthcare sector promises further blockbusters for investors. Cardiol Therapeutics impresses with its promising Phase II study of CardiolRx™ for the treatment of the heart disease pericarditis. The growing market for pericarditis treatments offers the Company great potential, which has also been positively noted by analysts. The Danish company Novo Nordisk is experiencing impressive growth thanks to its GLP-1-based diabetes and obesity drugs. The active ingredient is causing a stir in the celebrity scene as an off-label weight loss injection, further boosting the Company's sales figures. Bayer AG is facing up to its challenges. Despite slight revenue growth in the second quarter of 2024, profits declined. Nevertheless, CEO Bill Anderson believes the Company is on the right track, particularly thanks to progress in the pharmaceutical pipeline. We have three companies in focus.
Read
Commented by Juliane Zielonka on August 2nd, 2024 | 06:30 CEST
Transformation in full swing: Altech, Volkswagen, and Bayer focus on new technologies and markets
Shortly after the grandiose Olympic opening ceremony, Paris showed us what it means to sit in the dark. One day after the opening ceremony, the inhabitants of the Seine were hit by a power outage. Speculation as to the cause ranges from a cyber attack to sabotage, similar to the recent arson attacks on the French rail network. But one thing is certain, it shows how fragile the power supply currently is. This is reason enough for Altech Advanced Materials to press ahead with the development of its stationary solid-state battery. A type of local battery power plant ensures a stable power supply, even with fluctuations in the grid due to wind and solar energy. The German company has another profitable development up its sleeve for the EV market. Volkswagen continues to focus on its electric vehicles and can look forward to increased sales in China. Nevertheless, the Wolfsburg-based company must make considerable savings to remain profitable. The results of the first half of the year provide deep insights. Additionally, for 27 million women in the US, ones battery can be figuratively "empty" at times. Fatigue, hot flashes, and nervousness are classic symptoms of menopause. 27 million is the market size of menopausal women that Bayer AG now aims to capture with a very special medication...
Read
Commented by Juliane Zielonka on August 1st, 2024 | 07:45 CEST
Commodities, Travel, Defense: Almonty, Lufthansa, and Rheinmetall in focus
Global tensions offer enormous potential for investors. Given the conflicts with China and Russia, the US urgently needs to reorganise its supply chains for defense raw materials. Almonty Industries, for example, is gaining strategic importance for the US defense industry with its Sangdong project in South Korea. Meanwhile, German airline Lufthansa is struggling with price pressure and rising costs. The management is aware of the challenges and continues to pursue its strict turnaround strategy. Investors should be prepared for profit warnings here. Despite Russian threats, defense contractor Rheinmetall is expanding in Eastern Europe, with new projects in Hungary and Ukraine. Where is an investment currently proving lucrative?
Read
Commented by Juliane Zielonka on July 25th, 2024 | 07:45 CEST
Plug Power, Carbon Done Right, BASF: Raising capital, climate protection projects, and cost optimization for returns
The energy sector is undergoing radical change, with far-reaching consequences for companies across various sectors. The hydrogen specialist Plug Power is struggling with financial bottlenecks despite state subsidies and has to carry out a capital increase on unfavourable terms. The sustainability company Carbon Done Right reports initial successes with its reforestation project in Sierra Leone. The Canadians are thus further establishing themselves in the growing market for CO₂ certificates. The chemical and agricultural company BASF is responding to the changing conditions in Germany by closing plants. The energy transition requires not only technological innovations but also new business models and flexible adaptation strategies. Which of the three companies will win the race this time?
Read
Commented by Juliane Zielonka on July 19th, 2024 | 07:00 CEST
Globex Mining, Barrick Gold, Amazon - Gold miners and data collectors: On the hunt for valuable resources
Gold has always been a safe haven for minimizing risk in a portfolio. The long-established exploration company Globex Mining boasts over 200 properties with various valuable metals in its portfolio. Recently, Globex acquired additional gold fields through a swap deal. Shareholders benefit from the ingenious strategy of preserving the value of the Company's shares - without dilution. The prospects for top dog Barrick Gold are also excellent. Analysts are also confident about Barrick's growth thanks to increased production and a further rise in the gold price. For Amazon and AWS, however, data is the new gold. Smart developers are the most valuable resource as an investment in the future. With a global AI tour in strategically important countries such as India, Brazil, the UK, and France, the tech giant is attracting talent and promoting developments in artificial intelligence. Who is the best hunter of these three candidates and offers the highest added value for investors?
Read